Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID‐19 Pandemic
Based on an analysis of death certificates, the marked decline in HCM-related deaths of >50% achieved in the US general population during the 2 decades from 1999 to 2019 was substantially reversed (by 29%) during the subsequent 3-year COVID-19 pandemic.
Authors
- Ahmed Sayed (ORCID: https://orcid.org/0000-0003-0150-8917)
- Ethan J. Rowin (ORCID: https://orcid.org/0000-0002-3953-0143)
- Barry J. Maron (ORCID: https://orcid.org/0000-0002-1710-8670)
- Martin S. Maron (ORCID: https://orcid.org/0000-0002-9923-3853)
Institutions
- Ain Shams University (EG)
- Houston Methodist (US)
- Lahey Medical Center (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1161/jaha.124.037047
- Citations
- 2
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.78